Should NICE's threshold range for cost per QALY be raised? No.
Raftery
James
J
University of Southampton, Southampton SO16 7PX. raftery@soton.ac.uk
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005102:Health Expenditures; D006801:Humans; D004364:Pharmaceutical Preparations / Q000191:economics*; D011320:Primary Health Care / Q000191:economics; D019057:Quality-Adjusted Life Years; D013222:State Medicine / Q000191:economics*; D006113:United Kingdom
D004364:Pharmaceutical Preparations